Global database of 168 CAR-T cell therapy companies through 15 January 2019. This database includes all companies worldwide with CAR-T cell therapeutic assets or programs (wholly owned, licensed or co-developed) in any stage of development (from preclinical to commercial). It does not contain information about vendors to CAR-T companies (manufacturers of reagents, materials, and devices) or service providers.
For each company:
- Company name
- Link to company website if available
- Country of origin
- Phase of development (preclinical or clinical)
- Type of cell products
- Key partner or licensee/licensor
Updates from Aug 2018 to Jan 2019:
- 19 companies added
- 1 company removed (Novartis acquired Endocyte)
- 6 key partners/ licensee-licensor updates
- 3 phase of development updates
Original file posted Aug 2018: 150 companies (63 in China and 87 in other countries).